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ABSTRACT 
 
Periodontitis has been associated with systemic diseases such as diabetes and 
atherosclerosis, cardiovascular diseases, and even chronic kidney disease (CKD) through 
low-grade systemic inflammation, although no causality can be drawn. CKD is an 
increasing problem worldwide, and has adverse effects on oral health. The main risk 
factors of CKD are diabetes mellitus (DM), hypertension and obesity. Diabetic nephropathy 
is the main reason for entering dialysis in Finland and cardiovascular diseases (CVD) play 
a crucial role in mortality among CKD patients.   
The general aim of this thesis was to study oral health with an emphasis on periodontitis 
among CKD patients, and to determine the differences between diabetic nephropathy and 
other CKD patients (Study I) and whether salivary MMP-8 concentration can reflect an oral 
inflammatory burden at the predialysis stage (Study II). In the follow-up prospective cohort 
study (III), the goal was to examine whether oral inflammatory burden was associated with 
mortality among the study patients and clarify the cause of death of patients who had been 
enrolled in our previous study. A further aim was to compare oral health at the predialysis 
stage and at follow-up (Study IV).  
The hypotheses were that diabetic nephropathy patients have worse oral health than other 
CKD patients, at both predialysis and post-transplantation stages, and that salivary MMP-8 
associates with worse oral inflammatory burden. The mortality rate was assumed to be 
higher among diabetic nephropathy patients. The main expected reason for death was 
cardiovascular disease. 
This series of studies were further clinical oral investigations of CKD patients originally 
examined in 2000?2005 in the Department of Oral and Maxillofacial Diseases of Helsinki 
University Hospital at the predialysis stage (Vesterinen et al. 2011). The periodontal health 
of 144 CKD patients was now studied in more detail at the predialysis stage, and 118 
salivary samples were analyzed for MMP-8. Of these 144 patients, 53 took part in the 
follow-up study (2013?2015); 65 patients had died, and 26 had dropped out.  
The same periodontist (HR) conducted the clinical oral examination at the predialysis and 
post-transplantation stages, and the patients underwent a full clinical and radiographic oral 
examination. Radiological- and salivary analyses, questionnaires, hospital-, and mortality 
records were available for the study. The severity of the periodontitis was assessed using 
??
?
the definition of the Centers for Disease Control and Prevention/the American Academy of 
Periodontology (CDC/AAP) whenever possible, and other indices used were the 
Periodontal Inflammatory Burden Index (PIBI) (Lindy et al. 2008), the Total Dental Index 
(TDI) (Mattila et al. 1989), and the DMFT index (WHO 1997).  
The clinical oral parameters of patients with diabetic and other CKDs were analyzed, at 
both baseline and follow-up. 
Patients with diabetic nephropathy indeed had worse oral health at the predialysis stage, 
with two or more sites having periodontal pocket depths (PPD) of ?????, and higher TDI 
scores than the patients with other CKDs (p< 0.05), (Study I). Higher salivary MMP-8 
concentration was associated with worse oral health (deep periodontal pockets, higher 
PIBI and TDI) than with lower MMP-8 concentration (p< 0.05), (Study II). 
The 157-month follow-up study showed that the most frequent causes of death were 
cardiovascular diseases, followed by infection and cancer.  The survival rate of diabetic 
nephropathy (23.8%) patients and other patients with CKD (59.9%; log-rank test p < 
0.001) differed statistically significantly.  In the multivariable Cox regression model, fewer 
teeth, higher age, and diabetic nephropathy diagnosis were statistically significant 
independent risk factors for death.  The deceased patients had fewer teeth (p< 0.001) and 
higher TDI scores (p< 0.05) than those who survived (Study III). 
Most of the surviving patients who took part in the re-examination had undergone a kidney 
transplant (51/53), of which 46 transplants were functioning. Comparison of the two stages 
of kidney disease revealed that patients had more teeth, and more often had calculus, 
deep periodontal pockets, and higher TDI and PIBI scores (p< 0.05) at the predialysis 
stage than at the post-transplantation stage. Patients at the post-transplantation stage, 
however, took more drugs daily and had dental appointments more frequently in a year 
than the patients at the predialysis stage. Overall oral health was worse at the predialysis 
stage (Study IV). 
In conclusion, the present study supports the existing protocol of the Helsinki University 
Hospital, according to which oral examination, accurate diagnosis, and proper treatment of 
oral infection foci are mandatory at the predialysis stage for reducing systemic 
inflammation among CKD patients. Since diabetic nephropathy is associated with poorer 
oral health, this group of patients needs significant attention in oral care. 
??
?
INTRODUCTION 
 
Periodontitis is a bacteria-induced chronic inflammatory disease that affects a large portion 
of the adult population worldwide, also in Finland (Jin et al. 2011, Pihlstrom et al. 2005, 
Periodontitis:Current Care Guidelines 2016). Without treatment, it may lead to tooth loss in 
susceptible patients. CKD is defined as a deficiency in kidney structure or function that 
lasts over three months, and has an adverse effect on health (Inker et al. 2014). Its 
prevalence is over 10% in many countries, a number that is rising alarmingly (Eckardt et 
al. 2013). Principal risk factors for CKD are hypertension, diabetes, and obesity, although 
periodontitis as an inflammatory disease has also been proposed to be a non-traditional 
risk factor for CKD (Cignarelli and Lamacchia 2007, Fisher et al. 2008, Jha et al. 2013). 
Periodontitis may also accelerate poor glycemic control by increasing insulin resistance, 
whereas diabetes, in turn, may lead to abnormal hyper-inflammatory reaction to 
periodontal pathogens (Chapple et al. 2013, Southerland et al. 2006). 
The worldwide prevalence of diabetes among adults was 4.7% in 1980, compared to 8.5% 
in 2014 (WHO, Global report on diabetes 2016).  According to the International Federation 
of Diabetes, one adult in ten will have diabetes by 2040, corresponding to 642 million 
people (www.idf.org). The increasing prevalence of type 2 diabetes is explained by risk 
factors such as overweight, high blood pressure, impaired glucose tolerance, unhealthy 
diet, physical inactivity, and increasing age (www.idf.org).  
CKD is diagnosed by decreased glomerular infiltration rate (GFR) or by increased albumin 
concentration in the urea, i.e. albuminuria. When the functional capacity of kidneys falls 
below 10% of normal capacity, end-stage renal disease (ESRD) is diagnosed (Bots et al. 
2007). Treatment modalities for renal replacement therapy (RRT) are dialysis, either 
hemodialysis or peritoneal dialysis, and finally kidney transplantation. Diabetic 
nephropathy is the most common reason for dialysis treatment in Finland. 
Oral infections such as periodontitis should be regarded as one of the risk factors for the 
progression of CKD and diabetic nephropathy due to low-grade systemic inflammation. In 
fact, periodontitis may predict the development of ESRD and nephropathy in type 2 
diabetes (Shultis et al. 2007, Chapple et al. 2013).  
CKD patients are prone to premature death, mostly explained by CVD, followed by 
infections (Stenvinkel 2002, Kato 2008). Atherosclerotic CVDs are explained by 
??
?
dyslipidemia, hypertension, smoking, and inflammation, in which periodontitis and other 
oral infections may play a significant role (Tonetti et al. 2013).  
Oral health among CKD patients has mostly been studied during dialysis or the post-
transplantation stage (Bots et al. 2007, Summers et al. 2007, Craig 2008, Akar et al. 2011, 
Kaushik et al. 2013, Schmalz et al. 2016). Both stages have their own characteristics, 
which are also reflected in oral health.  
However, only a few studies have examined oral health at the predialysis stage which is, in 
fact, an important stage in the course of kidney disease (Souza et al. 2008, Thorman et al. 
2009, Vesterinen et al. 2011). At our hospital, all patients are referred for a dental 
examination at the predialysis stage, during which the foci of oral infections are diagnosed 
and treated prior to entering RRT.  
A ??????????????????????????????? and ???????????????????????????????????yielded 20 results, 
6 of which were from our research group (Vesterinen et al. 2007, 2011, 2012, Nylund et al. 
2015a, 2015b, Ruokonen et al. 2016). Twelve studies of the remaining 14 were studies of 
orally administered drugs or vitamins, and the remaining two were clinical studies, one 
from Sweden by Thorman and co-workers (2009), and the other from Brazil by Souza and 
co-workers (2008). 
The cross sectional study by Thorman and co-workers showed that uremic CKD patients 
in predialysis, hemodialysis or in peritoneal dialysis had worse overall oral health (higher 
DMFT index, more loss of attachment, more periapical- and mucosal lesions) than the 
healthy controls (Thorman et al. 2009).  
The Brazilian cross-sectional research by Souza and co-workers showed that the general 
oral health status was poor among most (233/286, 88%) CKD patients, regardless of their 
treatment modality (predialysis, hemodialysis, peritoneal dialysis, or transplantation). 
However, transplant patients had less oral halitosis than patients with other treatment 
modalities (Souza et al. 2008). 
A cross sectional study by our research group showed that CKD patients with diabetic 
nephropathy had lower stimulated salivary flow rates and more caries than patients with 
other kidney diseases at the predialysis stage (Vesterinen et al. 2011).  
???
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To the best of our knowledge, only one longitudinal clinical study has followed CKD 
patients from the predialysis to the post-transplantation stage, and this is our own research 
group???????? (Vesterinen et al. 2007). 
This present study is divided into two investigations: baseline (predialysis) and follow-up 
(post-transplantation) studies. The purpose of the first part (Studies I and II) was to study 
oral health with an emphasis on periodontal disease by comparing diabetic nephropathy 
with other CKD patients. Oral inflammatory burden was compared with salivary MMP-8 
concentration. In the second part (Studies III and IV), a longitudinal study examined the 
association between oral inflammatory burden and mortality and causes of death among 
CKD patients and, secondly, compared the oral health of the patients during their 
predialysis and post-transplantation stages.  
The results of this series of studies are expected to help clinicians understand the 
differences between the oral health, with an emphasis on periodontitis, of diabetic 
nephropathy and other CKD patients at different stages of kidney disease. A further 
purpose was to determine whether the treatment of oral infections at the predialysis stage 
is indeed effective. 
 
  
???
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REVIEW OF THE LITERATURE 
 
Common oral diseases 
Dental caries and periodontal diseases are the most prevalent biofilm diseases in oral 
cavities (Shay 2002, Rosier et al. 2014). These multifactorial diseases constitute a major 
economic burden worldwide, and like other behavioral biofilm diseases, could mostly be 
prevented by good oral self-care. According to the ?Health 2011? survey in Finland, one in 
five people (aged ????????????????the northern or southern part of the country had at least one 
caries lesion, and this was more common among men (28%) than women (14%) (Health 
2011 survey, www.julkari.fi/bitstream/handle/10024/90832/Rap068_2012_netti.pdf).?Along 
the same lines was the finding ????????????????????????????????????????????????????????????
4mm deep) was more common among men (70%) than among women (56%) (Health 2011 
survey).?
Other prevalent oral lesions include candidiasis, recurrent herpes labialis, recurrent 
aphthous ulcers, hairy tongue, and lichen planus (Gonsalves et al. 2007). Oral mucosal 
lesions can be classified as ulcerative, vesicular and bullous lesions; red, white or 
pigmented, and benign or malign (Greenberg et al. 2008). The most common opportunistic 
oral infection is oral candidiasis, which is mostly caused by Candida albicans. Other 
candida species found in oral cavities are C. glabrata, C. tropicalis, C. pseudotropicalis, C. 
guilliermondii, C. dubliniensis, and C. krusei (Jordan and Lewis 2004). Candidiasis is often 
described as affecting the very young, very old, or very sick (Greenberg et al. 2008). Its 
predisposing factors are, for example, immunosuppressive disease or medication, poor 
oral health, endocrine disorders, smoking, and hyposalivation (Greenberg et al. 2008). 
 
Signs and symptoms of the mouth 
Xerostomia is a subjective symptom of dry mouth which does not always go hand in hand 
with physical signs of salivary gland hypofunction (MacEntee and Donnelly 2016). 
Hyposalivation, as an objective term, is defined when unstimulated salivary flow rate is < 
0.1ml/min, and stimulated salivary flow rate is < 0.7 ml/min (Saleh et al. 2015). 
Medication such as antihypertensive drugs, antidepressants, and antihistamines; 
polypharmacy in general; radiation therapy; ageing; systemic diseases such as Sjögren?s 
???
?
syndrome or other rheumatic diseases; and diabetes may disturb salivary gland function 
and result in reduced salivary flow (Saleh et al. 2015, MacEntee and Donnelly 2016). 
Hyposalivation predisposes to many disorders such as dysphagia (difficulty in swallowing), 
dysgeusia (altered taste sensation), dysphonia, pain, burning mouth, and oral infectious 
diseases such as caries and periodontal diseases, or even life-threatening bacterial and 
yeast infections and aspiration pneumonia (Saleh et al. 2015, Mac Entee and Donnelly 
2016). 
 
About 90% of saliva is produced by the major salivary glands: the parotid, submandibular- 
and sublingual glands. Saliva is mainly composed of water (90%) with electrolytes and 
proteins such as immunoglobulins; and antifungal, antibacterial and digestive enzymes 
(Saleh et al. 2015). Normally daily saliva volume varies from 0.5 to 1 liters per day. Saliva 
is indeed an important lubricant of oral and upper gastrointestinal mucosa, and has 
antimicrobial, buffering and demineralization properties.  
 
Burning mouth syndrome (BMS) is defined as unknown chronic burning pain in oral 
mucosa with no explanatory factor. BMS has been linked to other chronic pain syndromes 
and is also associated with peripheral or central neuropathic disorder, but its pathogenesis 
and etiology remain unknown (Moisset et al. 2016).  
 
Pathogenesis of periodontal diseases 
Periodontal diseases (gingivitis and periodontitis) are historically known as bacteria-
induced inflammatory diseases that affect the supportive structures of the teeth 
(Socransky and Haffajee 1992). Gingivitis is a reversible process that affects gingiva, 
although it may develop into irreversible state periodontitis, in which the polymicrobial 
biofilm triggers the host response, leading to destruction of the periodontium and, finally, to 
tooth loss in a susceptible patient (Offenbacher 1996). It is now recognized that a dysbiotic 
biofilm is necessary for periodontitis to develop, but that in itself, it is insufficient to cause 
the disease.  Individual susceptibility to periodontitis is principally determined by the host?? 
immune-inflammatory response to microbiota (Preshaw 2008, van Dyke and van 
Winkelhoff 2013). Immunosuppressive state, genetic, dermatological, neoplastic, 
hematological or granulomatous disorders may also have periodontal manifestations 
(Page and Kornman 1997, Pihlstrom et al. 2005).  
???
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In 1998, Socransky and co-workers introduced six subgingival microbial complexes: 
?yellow?, ?green? and ?purple? complexes were considered early colonizers of the tooth 
surfaces, and Gram-negative ?orange? and ?red? complexes comprised ??????
periodontopathog????. These are Prevotella intermedia, Prevotella nigrescens, 
Peptostreptococcus micros, Campylobacter gracilis, Campylobacter rectus, 
Porphyromonas gingivalis, Tannerella forsythia, and Treponema denticola. 
Aggregatibacter actinomycetemcomitans (previously Actinomyces 
actinomycetemcomitans) is another species often seen in periodontitis, especially in young 
patients (Socransky et al. 1998).  Virulent factors such as fimbriae, adhesion molecules, 
proteases and leukotoxins help putative bacteria colonize and compete for ecological 
niches and to evade the host (Offenbacher 1996). The ?red? complex has shown the 
strongest association with periodontal pocket formation (Socransky et al. 1998).  
The oral cavity provides a habitat for over 700 bacteria species, of which 150?200 can be 
found in most individuals and 30?100 species in a single site (Gorr and Abdolhosseini 
2011, Hasan and Palmer 2014). However, new molecular techniques have shown that the 
number of species in the mouth may be thousands, although the role of most of them is so 
far unknown (Keijser et al. 2008). The mouth serves as a moist, warm environment, with 
non-shedding surfaces that enable the formation of thick, well-organized biofilm (Marsh 
and Devine 2011). Although periodontopathogenic biofilm is needed for the initiation of 
periodontitis, several systemic and local risk factors are involved in modifying susceptibility 
to the disease.  Genetic, ethnic, age, gender, environmental (nutrition, pH, atmosphere, 
temperature, smoking, diabetes, stress) and host defense factors determine the 
composition of oral microbiota and play an important role in disease expression 
(Offenbacher 1996, Marsh and Devine 2011). Smoking may affect the composition of the 
biofilm in general and may also affect the immune system and impair the host?? defense by 
inhibiting granulocyte function (Hilgers and Kinane 2004, Söder et al. 2002). 
???????????????????????????????????????????, changes in environmental conditions may 
disrupt the host-microbe homeostasis. An increase in the amount of biofilm triggers the 
host to increase gingival crevicular fluid (GCF), thus providing not only host defense 
molecules but also nutrients for harmful proteolytic and anaerobic bacteria (Marsh and 
Devine 2011). 
???
?
Since knowledge regarding the composition and synergistic effects of subgingival 
microbiota has expanded through the development of microbiological methods, 
periodontitis is now believed to be initiated not only by single microorganisms, but also by 
polymicrobial synergy and dysbiosis (PSD) (Hajishengallis and Lamont 2012, Lopez et al. 
2015).  In the ??????????????????????????????????????????????????????????????????????????
such as P. gingivalis have the capacity to modulate the host?? immune system and tip the 
balance from homeostasis to dysbiosis (Hajishengallis and Lamont 2012). The 
c???????????????????????????????????????the biofilm increases the communication of 
different species and the expression of virulence factors, thus elevating the pathogenicity 
of the entire community (Hajishengallis and Lamont 2012, Lamont and Hajishengallis 
2015).  
 
Host immune system  
The host defense mechanisms and innate and adaptive immunity work together to try to 
preserve health and prevent disease (Table 1). 
Innate immunity comprises non-specific mechanisms such as the barrier function of the 
epithelium and specific pattern recognition receptors (PRRs) that recognize bacterial 
substances such as lipopolysaccharides (LPS), GCF with antimicrobial peptides (AMPs), 
polymorphonuclear leucocytes (PMN) and macrophages, and saliva with protective 
enzymes such as lysozyme and peroxidase (Gorr and Abdolhosseini 2011, Hasan and 
Palmer 2014).  
PMNs, the most important phagocytic cells, predominate in the early periodontal lesion in 
the gingival crevice and in the epithelium (Nussbaum and Shapira 2011). Neutrophils are 
considered the first line of defense during inflammation and infection.  They can kill 
bacteria intracellularly (oxygen dependent or oxygen independent pathways) or 
extracellularly, the latter having the potential to damage collateral connective tissue by 
releasing neutrophil cytoplasmic granules or neutrophil extracellular traps (NETs) into 
extracellular space (Brinkmann et al. 2004, Nussbaum and Shapira 2011).  Activated 
neutrophils release proteinases and are capable of producing cytokines and chemokines.  
Neutrophil disorders that affect neutrophil number (e.g. agranulocytosis, cyclic 
neutropenia), chemotaxis or function (leucocyte adhesion deficiency syndrome, Papillon-
???
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Lefevre syndrome) predispose individuals to infections such as periodontitis (Nussbaum 
and Shapira 2011).  
In periodontitis, the acute inflammatory response is protective. However, in susceptible 
patients, the response to remove inflammatory cells fails, and inflammation becomes 
chronic when adaptive immunity takes place, and plasma cells and lymphocytes 
predominate (Nussabaum and Shapira 2011, van Dyke and van Winkelhoff 2013). 
Adaptive immunity is characterized by specificity with an ?? ????????????????????
(Ebersole et al. 2016). This is triggered by cytokines, which activate cell-mediated (T-cell) 
and humoral immunity (B-cell). Bacterial antigens are presented by macrophages and 
dendritic cells to T- and B lymphocytes. Antibodies (IgA, IgG, and IgM) are secreted when 
B cells recognize antigens by cell surface immunoglobulins (Igs) (van Dyke and van 
Winkelhoff 2013). Secretory IgA inhibits bacterial adhesion to mucosal surfaces, thus 
preventing infection (Hasan and Palmer 2014).  More antibodies, enzymes and immune 
cells are then secreted into GCF by inflammation.   
T-cells, on the other hand, express CD4+ and CD8 cell surface proteins, which act as 
receptors for antigens. T-cell activation turns them into helper T-cells (CD4+), (producing 
interleukins) or cytotoxic T-cells (CD8) (van Dyke and van Winkelhoff 2013). 
 
Pro-inflammatory mediators   
Pro-inflammatory mediators comprise cytokines such as tumor necrosis factor-??????-????
interleukin (IL)-??????-6, and IL-8, chemokines, immunoglobulins and proteolytic enzymes, 
e.g. matrix metalloproteinases (MMP)-8 and MMP-9 (Rathnayake et al. 2013a). Cytokines 
do not work alone but in complex networks (Preshaw and Taylor 2011). The PRRs of 
innate immune cells (macrophages, dendritic cells and PMNs) recognize microbe-
associated molecular patterns (MAMPs) and produce pro-inflammatory cytokines. These 
cytokines further determine the pathway of T-cell differentiation and the subclasses of 
immunoglobulins (Preshaw and Taylor 2011). The balance between pro- and anti-
inflammatory cytokines determine the extent of periodontal destruction.  
 
Type I collagen is the main extracellular matrix component in periodontal tissues and its 
destruction is regarded as one of the key factors in the destruction of periodontal tissues 
???
?
(Golub et al. 1997). MMPs are groups of structurally alike proteolytic enzymes, capable of 
degrading extracellular matrix and basement membranes. Human 23 MMPs 
(collagenases, gelatinases, membrane-type MMPs, stromelysins and other MMPs) take 
part in organogenesis, normal tissue turnover, immunity response in periodontitis, and 
tissue destruction (Sorsa et al. 2004, 2006). The balance between MMPs and their 
regulatory proteins such as the tissue inhibitors of matrix metalloproteinases (TIMPs) may 
be disrupted by microbial virulence factors, hormones, cytokines and growth factors, 
resulting in tissue destruction, also seen in periodontitis, peri-implantitis and cancer. 
Collagenolytic matrix metalloproteinases collagenase-2 (MMP-8) and collagenase-3 
(MMP-13) have shown to associate with severe periodontitis (Sorsa et al. 2004, 2006, 
Leppilahti et al. 2011). MMP-8 is produced by PMNs, epithelial cells, fibroblasts, 
endothelial cells, monocytes, macrophages and plasma cells, and is the main collagenase 
in inflamed gingival tissue (Sorsa et al. 2004, 2006). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INNATE IMMUNITY                 ADAPTIVE IMMUNITY 
Epithelial barrier                 Lymphocytes 
Epithelial cells: e.g. AMPs, IL-1?, IL-8                Cell-mediated immunity (T-cells) 
Pattern recognition receptors (PRRs): e.g. TLRs               Humoral immunity (B-cells) 
Gingival crevicular fluid: e.g. AMPs, PMNs, complement      
PMNs 
Monocytes, macrophages 
Peripheral dendritic cells 
Mast cells 
Saliva: e.g. lactoferrin, lysozyme, peroxidase 
Table 1. The immune system 
AMP = antimicrobial peptide, IL = interleukin, TLR = toll-like receptor, PMN= polymorphonuclear leukocyte 
???
?
Prevalence and risk factors of periodontal diseases 
Periodontal infections (gingivitis and periodontitis) are common inflammatory disorders, 
affecting up to 90% of the world?s population, and severe periodontitis affects 
approximately 5?15% of the population worldwide (Papapanou 1996, Pihlstrom et al. 
2005, Demmer and Papapanou 2010). These percentages vary according to ethnicity and 
socioeconomic status, since non-white and people with low socioeconomic status are 
more often affected. Older age is related to periodontitis, perhaps because of the 
cumulative effects of true behavioral risk factors such as bad oral hygiene habits and 
smoking or underlying health and systemic risk factors such as diabetes (Lalla and 
Papapanou 2011, Scannapieco and Cantos 2016). According to the ?Health 2000? survey 
in Finland, the prevalence of gingivitis was 74% and periodontitis 64% (defined by at least 
one pocket with a ?????-deep periodontal pocket). A severe form of periodontitis (defined 
by at least one site with a ????-deep periodontal pocket) was detected in 21% of 
participants (Health 2000 Survey, http://www.terveys2000.fi/indexe.html).  
Periodontitis is a multifactorial disease with several risk factors, such as poor oral hygiene, 
smoking, and systemic disorders such as diabetes, rheumatoid arthritis, osteoporosis and 
obesity (Lockhart 2012). Periodontitis is characterized as a complex disease with 
polygenic variation (Laine et al. 2012). According to twin- and family studies, genetics 
could explain about 50% of susceptibility to periodontitis (Laine et al. 2012). However, 
although the risk factors for periodontitis at the individual level may be explained by 
genetic, microbial and environmental factors, no specific gene or gene polymorphism has 
been found that could explain all forms of periodontitis.   
 
Diagnostic methods of periodontitis 
Periodontitis usually develops without symptoms and is diagnosed conventionally by 
clinical (measuring PPD with bleeding on probing, loss of clinical attachment) and 
radiological (alveolar bone loss) examination. Putative periodontopathogens can be 
detected by routine analyses, cultivation or by PCR (Mostajo et al. 2011). However, these 
diagnostic methods provide information on destruction that already has occurred.  Proper 
diagnosis should determine whether the disease is present; identify the type, distribution, 
activity, and severity of the disease, and provide an explanation for the underlying 
pathologic process. 
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Interest is currently paid to the ????????????????????????????????????????????????????????
such host inflammatory biomarker neutrophil collagenase MMP-8, which can be detected 
in GCF and saliva (Pihlstrom et al. 2005, Sorsa et al. 2004, 2006, 2011). New 
inflammatory biomarkers and a combination of different markers are being researched.  
MMP-8 levels seem to increase in oral fluids due to periodontitis, and to decrease after 
treatment (Mäntylä et al. 2006, Rathnayake et al.2013a, Leppilahti et al. 2014a,b, 
Leppilahti et al. 2015, Nwhator et al. 2014). During periodontitis, MMP-8 is mainly 
produced by PMN cells. Smoking seems to reduce the levels of MMP-8 by suppressing 
inflammatory cells and reducing the flow rate of GCF and saliva (Mäntylä et al. 2006, 
Sorsa et al. 2011, Leppilahti 2014a). High baseline MMP-8 levels in smokers have shown 
to strongly predict weak treatment responses (Leppilahti 2014b).  
As mentioned above, host-derived biomarkers of tissue destruction can be detected in oral 
fluids such as saliva, GCF/ peri-implant sulcular fluid (PISF) and mouth-rinse. GCF/PISF is 
detected in one site with microliter levels, whereas saliva or mouth-rinse provide more 
comprehensive information in milliliter levels. Since saliva is easy to collect non-invasively, 
attention is nowadays paid on saliva and mouth-rinse as diagnostic tools. 
Higher salivary MMP-8 concentration has also been associated with, for example, 
systemic diseases such as diabetes, previous heart surgery (Rathnayake et al. 2013b), 
and acute myocardial infarction (Budunelli et al. 2011). Salivary biomarkers may thus 
reflect not only oral but also systemic inflammation (Miller et al. 2010, Rathnayake 2013a).  
 
Classification of periodontitis 
The WHO Community Periodontal Index of Treatment Needs (CPITN) or Community 
Periodontal Index (CPI), as later renamed, has been widely used in epidemiological 
studies (Ainamo et al. 1982). This index provides the highest score per mouth sextant. CPI 
ranges from 0 to 4, where 0 mirrors health, 1 equals bleeding, 2 equals calculus, 3 equals 
a pocket depth of 4mm or 5mm, and 4 mirrors a pocket depth of ????????????????the 
limitation of this index is that it only takes into account a few teeth with deepened 
periodontal pockets, and not attachment loss (Leroy et al. 2010). Today, epidemiological 
studies mainly use pocket depth measurement together with an assessment of attachment 
loss when classifying periodontitis. 
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The CDC/AAP have recommended using case definitions of severe, moderate and mild, or 
no periodontitis in epidemiological studies, (Table 2), (Page and Eke 2007). These 
definitions take into account periodontal pocket measurements in combination with clinical 
attachment loss (CAL). Severe periodontitis is defined as two or more teeth with a (CAL) of 
??????????????????? ????????, and one or more teeth with a pocket depth of ? 5 mm at 
interproximal sites. Moderate periodontitis is defined as two or more teeth with a CAL of ??
4mm at interproximal sites, or two or more teeth with a pocket depth of ? 5mm. None or 
mild periodontitis is recorded when the criteria of neither moderate nor severe periodontitis 
definition are fulfilled (Page and Eke 2007).  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Disease severity           Clinical attachment loss (CAL)                        Periodontal pocket depth (PPD)
  
Severe            ????????????? ????????????????????????*       ???????????????????????????? ?????????????????????? 
Moderate            ????????????? ????????????????????????*        ???????????????????????????? ???????????????????????* 
None or mild            Neither severe nor moderate form  
*not on same tooth 
CDC/AAP= Centers for Disease Control and Prevention / the American Academy of Periodontology   
Table 2. Definition of periodontitis by CDC/AAP 
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Classification of oral inflammatory burden 
Oral inflammatory burden can be assessed by recording different indices such as the PIBI 
and the TDI, as shown in Tables 3 and 4, (Mattila et al. 1989, Lindy et al. 2008). The 
DMFT index takes into account decayed, missing and filled teeth (WHO 1997). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
??????????????PPD+ 2 Nadv PPD) 
Nmod= number of sites with moderate periodontal lesions (4?5mm) 
???????????????????????????????????????????????????????????????? 
Table 3. Determination of Periodontal Inflammatory Burden (PIBI, 28 teeth) 
Table 4. Determination of Total Dental Index (TDI, 32 teeth) 
Oral Disease      Score 
Caries  no caries lesions   0 
  1?3 caries lesions   1 
  4?7 caries lesions or no teeth in maxilla or mandible 2 
  ? 8 caries or radix or no teeth  3 
Periodontitis  4?5mm deep periodontal pocket  1 
  ? 6mm deep periodontal pocket  2 
  Pus in gingival pocket   3 
Periapical lesions 1 periapical lesion or vertical bone pocket or both 1 
  2 periapical lesions   2 
  ? 3 periapical lesions   3 
Pericoronitis  Absent    0 
  Present    1? ?
? ? ? ? ??????????????????? ??? ?
PPD=periodontal pocket depth?
???
?
 
Prevention and treatment of chronic periodontitis 
Proper diagnosis is vital for accurate treatment.  In Finland, the Current Care Guidelines 
for periodontitis were generated by the working group set by the Finnish Medical Society 
Duodecim and the Finnish Dental Society Apollonia. They represent evidence-based 
guidelines for clinical practice, diagnosis, and the treatment of chronic periodontitis 
(Periodontitis: Current Care Guidelines, 2016).  Periodontal treatment primarily targets 
professional mechanical bacterial debridement, i.e. scaling and root planing, and patients? 
self-care to eliminate biofilm and plaque retentions and to prevent the re-colonization of 
bacteria. Behavioral motivations, for example, smoking cessation are an essential part of 
treatment. Local or systemic antibiotics, laser treatments, and surgery may be combined 
with mechanical treatment. The benefits of systemic antibiotics should be balanced against 
their systemic side effects and antibiotic resistance (Jepsen and Jepsen 2016). Systematic 
maintenance care is needed to achieve long-term success. 
Host modulation therapy, such as low dose doxycycline (LDD) treatment has proven to be 
a viable option for treating chronic inflammatory periodontal disease (Lalla and Papapanou 
2011). LDD inhibit MMPs without an antimicrobial effect, but still suppresses connective 
tissue breakdown (Golub et al. 1992). The purpose of host modulation is to return the 
balance between pro- and anti-inflammatory mediators (Preshaw 2008). A recent review 
article claims that host modulation therapy, a 20 mg subantimicrobial dose of doxycycline 
(SDD) twice daily, is effective not only in periodontitis but also in diabetes, arthritis, and 
among postmenopausal women with local and systemic bone loss (Golub et al. 2016).  
 
Kidneys 
Anatomy and function 
Two bean-shaped kidneys, at the level of T12 to L3 vertebrae lie on each side of the spine 
in the retroperitoneal space. Kidneys are about 10 cm long, 5 cm wide and 2.5 cm thick, 
and are partly protected by the lowest rib (Moore 1992). They contain about one million 
functional units, nephrons with glomerulus and long tubules in which reabsorption of many 
solutes and water take place (Eckardt et al. 2013). See Figure 1 for details. 
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Kidneys remove the excretion end products of metabolism, regulate erythrocyte production 
using the erythropoietin hormone, regulate blood pressure through the renin-angiotensin 
system, participate in calcium homeostasis by hydroxylating D vitamin to its active form, 
regulate electrolyte concentrations, and maintain acid-base and fluid balance (Moore 
1992, Craig 2008, Thorman et al. 2009). Kidney function is assessed by GFR, which can 
be estimated using a serum creatinine concentration (Craig 2008).  
Laboratory tests may include complete blood count, serum electrolytes, blood urea 
nitrogen, calcium, the parathyroid hormone, glucose, and glycosylated hemoglobin. Urine 
tests may involve analyzing, for example urine electrolytes, creatinine, and total protein 
concentrations. Imaging techniques including renal ultrasound are also routinely used 
(Greenberg et al. 2008).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Kidney and nephron (http://unckidneycenter.org)  
Source: with permission from the UNC Kidney Center 
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Classification, prevalence and causes of kidney diseases 
Acute kidney injury is defined as changes in kidney function that ????????????? ??????
(Eckardt et al. 2013). According to the US National Kidney Foundation - Kidney Disease 
Outcomes Quality Initiative?? (NKF-KDOQI) clinical practice guidelines, CKD is defined as 
abnormalities in kidney structure or function lasting over three months, with implications for 
health (Inker et al. 2014). Classification of CKD is based on a cause, GFR and albuminuria 
categories (Inker et al. 2014) (Table 5). At the Helsinki University Hospital, the predialysis 
stage is defined as mid-stages 4 and 5.  According to KDIGO (Kidney Disease: Improving 
Global Outcomes), albuminuria is categorized as Categories 1 to 3. Category 1 represents 
normal or mildly increased excretion with an albumin excretion rate (AER) of < 30mg/24 
hours. In category 2, AER is 30?300 mg/24 hours (moderately increased excretion), and in 
category 3, AER is > 300 mg/24hours, representing severely increased excretion (Inker et 
al. 2014). 
 
 
 
 
 
 
 
 
 
The prevalence of CKD is increasing worldwide, and affects 8?16% of individuals globally 
(Jha et al. 2013). The prevalence of acute kidney disease varies because of several 
different definitions and is estimated to be over 1% (Lameire et al. 2013). 
The main risk factors of chronic kidney failure are diabetes, hypertension, and obesity in 
developed as well as many developing countries, while glomerulonephritis and unknown 
reasons are more common in Asia and sub-Saharan Africa (Cigranelli and Lamacchia 
2007, Jha et al. 2013). Other etiological causes of CKD are systemic autoimmune 
CKD stage   Kidney function                      GFR (ml/min/1.73 m2) 
1  normal    > 90 
2  mildly impaired  60?89  
3  moderately impaired  30?59 
4  severely impaired  15?29 
5  end stage kidney failure  < 15 
Table 5. Classification of Chronic kidney disease (CKD) stages by GFR 
GFR= glomerular filtration rate 
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diseases, polycystic kidney disease, obstructive uropathy, chronic pyelonephritis, and 
other low-grade systemic inflammatory diseases, such as periodontitis (Fisher et al. 2008, 
Eckardt et al. 2013). In Finland, diabetic nephropathy is the most common cause for 
dialysis treatment, followed by glomerulonephritis, polycystic kidney disease and 
nephrosclerosis (Finnish Registry for Kidney Diseases 2014). 
Acute kidney injury, on the other hand, is often associated with bacterial infection, sepsis 
or ischemia-reperfusion injury (Imig and Ryan 2013). 
Diabetes as an inflammation-associated disease may contribute to renal inflammation and 
further to the development of diabetic nephropathy. Renal inflammation can result from 
metabolic and renal hemodynamic routes caused by hyperglycemia, reactive oxygen 
species (ROS), and AGEs, or glomerular hypertension and endothelial dysfunction (Imig 
and Ryan 2013). 
 
End-stage renal disease   
When CKD has progressed to ESRD, RRT (dialysis or kidney transplantation) is needed. 
ESRD state is reached when the functional capacity of kidneys has decreased below 10% 
of their normal function (Bots et al. 2007). Over two million people worldwide were treated 
for ESRD in 2010, but because of disparities in access to RRT, an estimated six million 
people were untreated (Robinson et al. 2016). In 2014, 4540 patients were in RRT in 
Finland, of which 343 were in peritoneal dialysis treatment, 1474 in hemodialysis 
treatment, and 2722 were living with kidney transplants (Finnish Registry of Kidney 
Diseases 2014). 
Kidney transplantation is the preferable choice of ESRD as it improves survival and quality 
of life, and is cost-effective compared to dialysis (Jensen et al. 2014, Ortiz et al. 2014, 
Sanchez-Escuredo et al. 2015, Robinson et al. 2016,). In 2014, 240 kidney transplants 
were made in Finland (Finnish Registry for Kidney Diseases 2014). Prior to entering 
kidney transplantation, the candidate patient must be screened for infections, including 
oral infections, before immunosuppressive medications can be administered. 
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Immunodeficiency in chronic kidney disease 
CKD is regarded as an immunosuppressive state due to factors such as uremic toxins, 
immune cell dysfunction, mainly caused by hypercalcemia related to secondary 
hyperparathyreoidism, and a lack of supportive cytokines, D-vitamin deficiency, and 
dialysis treatment (Hannula 2009). Immunosuppressive therapy understandably also 
causes immunodeficiency. 
 
Mortality among kidney patients 
Patients with ESRD have higher death rates compared with general population (de Jager 
et al. 2009). CVD are the main causes of death among patients with CKD, followed by 
infections (Stenvinkel 2002, Kato et al. 2008.) Traditional risk factors for atherosclerotic 
CVD are dyslipidemia, diabetes, hypertension, and smoking, which do not, however, 
explain all cases of CVDs (Stenvinkel 2002). Other risk factors include genetic 
components such as family history of atherosclerotic disease, male gender, metabolic 
syndrome, obesity, depression, and lack of exercise (Lusis 2000).  Oxidative stress and 
inflammation have been postulated to be non-traditional risk factors for CVD (Stenvinkel 
2002). Aortic stiffness has also been explained by excess phosphate in the arteries due to 
secondary hyperparathyreoidism in CKD, which is already seen in patients with CKD stage 
3 (Hannula 2009).  
According to the European Dialysis and Transplant Association Registry, the five-year 
survival rate was 52% for patients who underwent dialysis treatment and 91% for patients 
who had undergone a kidney transplant (Pippias et al. 2015). In Finland, age-standardized 
mortality among patients receiving RRT has decreased over the years, (85 deaths per 
1000 patient years), reflecting good quality of treatment (Finnish Registry for Kidney 
Diseases 2014).  
 
 
 
 
 
???
?
Oral infections and systemic diseases   
 
?????????????????, such as oral infection, has been held responsible for the initiation and 
progression of a number of systemic diseases since the late 19th and the early 20th century 
(Scannapieco 1998).  However, the theory did not become popular at the time, partly due 
to a lack of sufficient evidence for classifying and identifying oral microorganisms. 
 
Since dental treatment has developed in recent decades, and the world?? population is 
aging, it is logical that people retain natural teeth in their mouths for longer than before. 
However, teeth and periodontal niches may serve as reservoirs for microbiota and might 
predispose to systemic infections. These are seen especially in the elderly, whose visual 
and motoric skills for oral self-care have deteriorated; in immunocompromised patients 
suffering from chronic inflammatory diseases such as diabetes, CKD or rheumatoid 
arthritis; or in patients undergoing immunosuppressive treatment. 
Oral diseases such as dental caries, mucosal lesions and periodontitis, or dental 
procedures such as tooth extraction, periodontal or endodontic treatment, or even tooth 
brushing and flossing may help the invasion of oral micro-organisms into the systemic 
circulation through dental pulp, mucosal surface or periodontal pockets. Transient oral 
bacteremia predisposes to systemic infections such as endocarditis, joint infections and 
brain abscesses, and upregulates inflammatory reactions, rendering the body liable to 
other systemic conditions and other diseases such as diabetes or atherosclerosis 
(Lockhart et al. 2008, 2009, 2012, Zhang et al 2013, Scannapieco et al. 2016). 
The association between periodontitis and CVD (among other systemic chronic diseases) 
is well known (Meurman et al. 2004). A recent study suggested that endodontic lesions are 
also independently associated with coronary artery disease, especially with acute coronary 
syndromes explained by systemic inflammation (Liljestrand et al. 2016). 
 
Periodontitis and systemic inflammation 
Although no causal relationship can be drawn between periodontitis and systemic 
diseases, many studies have shown a possible association with diabetes, cardiovascular 
diseases, pregnancy complications, pneumonia, chronic obstructive pulmonary disease, 
rheumatoid arthritis, obesity, metabolic syndrome, cancer, and CKD (Desvarieux 2005, 
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Lalla and Papapanou 2011, Lockhart et al. 2012, Linden et al. 2013, Tonetti and Van Dyke 
2013). An inflamed periodontal pocket epithelium of 8?20 cm2 is an open door for bacteria 
and their products. The latter include LPS, peptidoglycan (PGN), cytotoxins, proteases and 
haemagglutinins, as well as locally produced pro-inflammatory mediators such as IL-1?, 
IL-6, TNF-?, and prostaglandin E2 (PGE2) which is produced by host cells (neutrophils, 
macrophages and lymphocytes) into bloodstream (Hujoel et al. 2001, Preshaw and Taylor 
2011, van Dyke and van Winkelhoff 2013). These pro-inflammatory mediators may act as 
inflammatory stimuli at a distant site and cause problems for the patient (Lalla and 
Papapanou 2011).  
 
Diabetes  
DM is a metabolic disorder with an abnormal blood glucose level caused by lack of insulin 
related to pancreatic beta-cell dysfunction, or insulin resistance (Chapple et al. 2013). As a 
metabolic disorder, insulin disturbances may lead to abnormal glucose, fat and protein 
metabolisms, creating different pathologies in multiple organs (Southerland et al. 2006). 
According to the World Health Organization (WHO), 442 million people worldwide were 
suffering from diabetes in 2014, compared to 108 million in 1980, and the number is still 
increasing (WHO 2016). Diabetes caused 1.5 million deaths in 2012 worldwide (WHO 
2016). 
Type-1 diabetes (DM1) (5?10% of cases) is a form that results from autoimmune 
destruction of the insulin-producing beta cells in the pancreas.  The subsequent lack of 
insulin leads to increased blood and glucose levels. Type-2 diabetes (DM2) is a metabolic 
disorder characterized by hyperglycemia in the context of insulin resistance and a relative 
lack of insulin. DM1 mostly affects children, whereas DM2 mostly affects older patients 
(85?90%), but may also be seen among children. Gestational form affects 1?5% of cases 
(Otomo-Corgel et al 2012).  
DM1 results from a complex interaction between genes and environmental factors, 
although no specific environmental risk factor has been found (WHO 2016). In contrast, 
well-known risk factors for DM2 are obesity and overweight, combined with genetic 
background, physical inactivity, and smoking (WHO 2016). 
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Glycosylated hemoglobin level (HbA1c) is indicative of the metabolic control in the 
preceding two to three months. According to the American Diabetes Association, the 
diagnosis of diabetes in adults is made using two tests of Hb????????????????????mol) 
(Standards of Care 2016).   
With elevated HbA1c, diabetes may lead to known complications such as retinopathy, 
neuropathy, nephropathy, cardiovascular complications, and delayed wound healing 
(Otomo-Corgel et al. 2012). Löe suggested in 1993 that periodontitis should be recognized 
as the sixth complication of DM (Löe 1993). Today, the bidirectional relationship between 
these two chronic diseases, diabetes and periodontitis, is well accepted, and both may be 
present for years before symptoms (Taylor et al. 1998, Chapple et al. 2013). 
 
Hyperglycemia and periodontitis 
Different mechanisms have been proposed to link diabetes to periodontitis 
(microangiopathy, alterations in GCF, collagen metabolism, subgingival flora, genetic 
factors, and host response) (Taylor et al. 1998).  Many cross-sectional and longitudinal 
studies, together with meta-analyses, have shown a greater prevalence of advanced 
periodontitis among diabetic versus non-diabetic patients (Oliver & Tervonen 1994, Collin 
et al. 1998, Khader et al. 2006). Emrich and co-workers found that diabetes tripled the risk 
of periodontitis among 1 342 PIMA Indians (Emrich et al. 1991). Taylor and co-workers 
confirmed these cross-sectional statements with a longitudinal study of PIMA Indians, 
which showed non-insulin dependent diabetes mellitus (NIDDM) to be a risk factor for 
more severe alveolar bone loss progression in two-year follow-up (Taylor et al. 1998).  
Hyperglycemia leads to an abnormal hyper-inflammatory response to 
periodontopathogens in the periodontium (Southerland et al. 2006, Nishimura et al. 2007, 
Otomo-Corgel et al. 2012). Cell surface receptors (RAGEs) for advanced glycation end 
products (AGEs) in gingiva are expressed, and RAGE-AGE interaction leads to immune 
dysfunction, exaggerated inflammatory response and oxidative stress, thus further 
accelerating AGE and pro-inflammatory cytokine formation, the destruction of tooth 
supported structures, and impaired wound healing (Lalla and Papapanou 2011, Chapple et 
al. 2013, Taylor et al. 2013).  
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So far, hyperglycemia has shown no relationship with periodontal microbiota (Taylor 
2013). However, diabetic patients with periodontitis seem to have elevated numbers of 
pro-inflammatory mediators such as IL-1?, IL-6, and increased RANKL/OPG ratios 
compared with systemically healthy controls with periodontitis. This partly explains bone 
resorption in periodontitis (Salvi et al. 1997). However, it is noteworthy that diabetic 
patients with well-controlled blood sugar levels are not at an increased risk of periodontitis 
(Kowall et al. 2015). 
 
Impact of periodontitis on diabetes 
Untreated periodontitis may increase systemic pro-inflammatory mediators, causing insulin 
resistance. The European Federation of Periodontology (EFP) and the American Academy 
of Periodontology (AAP) have confirmed that in patients with severe periodontitis, the 
disease adversely affect blood glucose levels (HbA1c) (Chapple et al. 2013). 
Taylor and co-workers were the first to show, in a five-year follow-up study in 1996, that 
severe periodontitis at baseline among the NIDDM Gila River Indian Community (tribe of 
PIMA Indians, Arizona) resulted in poorer glycemic control (HbA1c > 9%) than that among 
those without severe periodontitis (Taylor et al. 1996). Severe periodontitis was assessed 
by attachment loss of 6 mm or more on at least one index tooth, and radiographic bone 
loss of 50% in at least one tooth. 
A study of 9 296 nondiabetic participants of NHANES I (National Health and Nutrition 
Examination Survey) and its Epidemiologic Follow-up Study (NHEFS) showed that severe 
tooth loss at baseline resulted in the incidence of diabetes with an odds ratio (OR) of 1.7 
(p< 0.05), (follow-up period of 17 ± 4 years) (Demmer et al. 2008).    
A recent systematic Cochrane collaboration review of 35 studies on diabetic patients found 
that the mean percentage reduction in HbA1c by conventional periodontal therapy was 
0.29% at three to four months (Simpson et al. 2015).  
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Atherosclerotic cardiovascular disease 
Atherosclerotic cardiovascular diseases (ACVD) comprise coronary heart disease (angina 
pectoris and myocardial infarction), ischemic cerebrovascular disease (TIA and stroke), 
and peripheral arterial disease (Tonetti et al. 2013). 
As classic risk factors for ACVD, such as hypertension, diabetes, smoking and 
hypercholesterolemia explain only 30?60% of the disease, chronic infection and 
inflammation has been proposed as another risk factor (Scannapieco 1998, Li et al. 2000). 
Since 1989, the association between dental infections and acute myocardial infarction has 
been extensively studied. At our hospital, Mattila and co-workers found that patients with 
acute myocardial infarction had worse oral health than age- and sex-matched controls 
(Mattila et al. 1989). A recent study by Beukers and co-workers showed an independent 
association between periodontitis and ACVD in over 60 000 Dutch patients (Beukers et al. 
2016). 
Vascular cell wall injury (mechanical, immunological or biochemical) leads to adhesion 
molecule expression by endothelial cells. Monocytes adhere and migrate through the cell 
wall, phagocytose low-density lipoproteins and release pro-inflammatory cytokines, 
inducing inflammatory cascades (Cullinan and Seymor 2013). LPS from Gram-negative 
bacteria is toxic to endothelial cells, and promotes adhesion molecule expression. LPS 
may also help macrophages transform into foam cells, promoting inflammation and further 
atherosclerosis (Cullinan and Seymor 2013). Bacteria and their products from oral cavities 
may thus activate host inflammatory mechanisms in the periphery, favoring the formation, 
maturation and exacerbation of atheroma (Tonetti et al. 2013).  
 
Chronic kidney disease 
Inflammation and atherosclerosis, both related to periodontitis, are shown to predispose 
patients to CKD (Scannapieco and Cantos 2016). Rahmati and co-workers were the first to 
show an association between serum IgG to periodontal bacteria (P.gingivalis) and 
elevated level of C-reactive protein in hemodialysis patients (Rahmati et al. 2002). A cross-
sectional study by Kshirsagar and co-workers showed that a reduction in GFR was 
connected to periodontal disease (Kshirsagar et al. 2005). Chambrone and co-workers in 
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turn concluded in their systematic review that fairly strong evidence exists to support an 
association between periodontitis and CKD (Chambrone et al. 2013).  
 
Association between other systemic diseases and periodontitis 
Infection can be a risk factor for pregnancy complications such as preterm birth (< 37 
weeks of gestation) and low birth-weight (< 2500 g) infants. Oral inflammatory burden such 
as periodontitis may be one route of infection associated with preterm birth (Heimonen et 
al. 2009). Increased bacterial spreading or pro-inflammatory cytokines could affect the 
placenta and further drive preterm birth forward. However, many studies show opposite 
results, and more research is needed (Cullinan and Seymor 2013, Walia and Saini 2015). 
A systematic review and meta-analysis by Kim and co-workers concluded that mothers at 
a high risk of preterm birth could benefit from periodontal treatment (Kim et al. 2012).  
In hospitalized and elderly patients, aspirated microbiota may cause bacterial aspiration 
pneumonia (Garcia et al. 2001, Scannapieco and Cantos 2016). Normally, healthy 
subjects may aspirate 50% of oropharyngeal contents, which are eliminated by the host 
immune system without harm (Garcia et al. 2001). Aspiration pneumonia is often 
correlated with dysphagia, but other reasons such as a high number of decayed teeth, 
Staphylococcus aureus and Streptococcus sobrinus bacteria in the saliva, the presence of 
P. gingivalis in plaque, dependence in feeding and oral care, chronic obstructive 
pulmonary disease, and diabetes have all shown a correlation with aspiration pneumonia 
(Terpenning et al. 2001). 
Chronic obstructive ??? ??????????????????????????????????????????? 40-years 
worldwide, and is a leading cause of morbidity and mortality (Halbert et al. 2006, 
Scannapieco and Cantos 2016). Inflammation, mostly due to toxic chemicals from 
smoking, is the most significant factor in the development of COPD. Chronic infection such 
as periodontitis has shown to associate with COPD by triggering pro-inflammatory events 
and further influencing the frequency of disease exacerbation (Scannapieco and Cantos 
2016).  
Inflammation plays a crucial role in autoimmune diseases such as rheumatoid arthritis. In 
the light of current knowledge, genetic and environmental factors trigger autoantibodies to 
autoantigens such as citrullinated proteins (Scannapieco and Cantos 2016). One 
explanation for the association between periodontitis and rheumatoid arthritis could be the 
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ability of P. gingivalis to produce peptidylarginide that can citrullinate proteins (Wegner et 
al. 2010). 
Obesity is known to be a hyperinflammatory state with insulin resistance. A recent study by 
Suvan and co-workers showed an independent association between periodontitis and 
obesity (Suvan et al. 2015). Obesity may indeed alter the inflammatory state, thus also 
predisposing the individual to periodontitis (Suvan et al. 2015). 
 
Oral manifestation of chronic kidney disease 
CKD may be accompanied by other systemic diseases with oral mucosal manifestations. 
Aphthous ulcers of oral mucosa may be associated with Behcet?s disease, which is linked 
to rapidly progressive glomerulonephritis; or with systemic lupus erythematosus (SLE), 
which is characterized by lupus nephritis (Summers et al. 2007). ?Strawberry gingivitis??
may be the first manifestation of systemic vasculitis, Wegener?s granulomatosis 
(Ruokonen et al. 2009). Macroglossia may be due to deposits of amyloids (Summers et al. 
2007).  
CKD patients may also present many oral changes due to medication or the disease itself 
affecting teeth, oral mucosa, periodontium, and the salivary glands (Summers et al. 2007, 
Akar et al.  2011). Reported changes in teeth include pulp narrowing, enamel hypoplasia, 
dental caries, and periodontitis (Gaili et al. 1991, Vesterinen et al. 2011, Kshirsagar et al. 
2005, Summers et al. 2007). Hyposalivation due to diabetes or medication is harmful, as it 
increases microbial colonization, thus enhancing oral diseases. 
The different stages of CKD, namely predialysis-, dialysis and the post-transplantation 
stage may manifest in different ways in oral health. Different CKD diagnoses, such as 
diabetic nephropathy, have also shown characteristic oral health manifestations. 
 
Predialysis stage 
Uremic patients have shown a worse DMFT index and more periodontal loss of 
attachment and periapical lesions than sex- and age-matched controls (Thorman et al. 
2009, Vesterinen et al. 2011). At the predialysis stage, protein intake is restricted, while 
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sufficient energy is secured by intake of carbohydrates (Thorman et al. 2009). This may 
detrimentally affect dental and oral health.  
Diabetic patients should be informed of their greater risk of periodontitis, the adverse 
effects of poor glycemic control on periodontitis, and the increased risk of systemic 
problems such as cardiovascular complications or the progression of CKD (Chapple et al. 
2013).  
 
Dialysis 
Oral health often deteriorates in patients receiving hemodialysis therapy (Schmalz et al. 
2016). As hemodialysis treatment is time consuming, usually requiring four to six hours 
three times per week, treatment may be stressful for the patient. This may lead to having 
no strength to maintain proper oral health. Moreover, dialysis is regarded as an 
immunosuppressive state which further affects oral health.  
Symptoms such as oral malodor (ammonia-like smell, typical for uremic patients), dry 
mouth (xerostomia), and taste changes (metallic taste) have been reported in dialysis 
patients (Kaushik et al. 2013). Medication such as antihypertensive drugs and diuretics 
may predispose to poor oral health through hyposalivation. This may also affect denture 
retention and cause difficulties in speaking and eating. The reduction of fluid intake may 
cause general weakening and a reduced salivary flow rate. These changes may lead to 
problems in mucosa and predispose to oral fungal and viral infections, as well as coated 
tongue, sialdenitis, oral ulceration, enamel hypoplasia, increased dental calculus 
formation, and caries development (Summers et al. 2007, Akar et al. 2011, Kaushik et al. 
2013, Schmalz et al. 2016). In contrast, some studies have shown a prevalence of 
reduced caries in ESRD, perhaps due to the protective, neutralizing role of urea in saliva 
and plaque (Al Nowaiser et al. 2003).  
In oral health care, attention should be paid to prolonged bleeding time after tooth 
extraction or periodontal treatment due to heparin administration in hemodialysis, drugs 
used for treatment (GFR is decreased), and the need for antibiotic prophylaxis (vascular 
access sites protection) (Craig 2008). 
 
 
???
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Post-transplantation stage 
Transplant patients may have oral manifestations such as gingival hyperplasia due to 
immunosuppressants (cyclosporine) and antihypertensive drugs (calcium channel 
blockers). Cyclosporine-induced gingival hyperplasia ranges from 22% to 58%, and is 
more prevalent among young patients and patients with increased dental plaque 
accumulation or an increased drug dosage (Craig et al. 2008, Akar et al. 2011).  
Transplant patients are also prone to virus infections, ulcers and oral malignancies 
(Summers et al. 2007). Fungal infections are found in 20?30% of transplant patients, and 
may manifest as angular cheilitis, pseudomembranous or erythematous ulcerations 
(Summers et al. 2007). In their two-year follow-up investigation, Bots and co-workers 
found that xerostomia and thirst decreased, and unstimulated salivary flow rate increased 
after kidney transplantation compared to dialysis state (Bots et al. 2007).  
Oral health care professionals should pay attention to the fact that a patient with a 
transplanted organ needs immunosuppressive drugs for the rest of their life. These drugs 
may predispose patients to oral inflammations and fungal and viral infections as well as 
malignancies or gingival overgrowth induced by cyclosporine and calcium channel 
blockers.  Therefore, oral examination of transplant patients calls for special attention, 
preferably in a specialist clinic (Kaswan et al. 2015, Rezvani et al. 2014). Antibiotic 
prophylaxis is mandatory when treating transplant patients. 
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AIMS OF THE STUDY 
 
This study examined the oral health of CKD patients in detail, with an emphasis on 
periodontal disease; first at baseline (predialysis stage, Study I and Study II), and 
secondly at follow-up (post-transplantation stage, Study III and Study IV). Studies I and II 
are based on the patients previously described by our group (Vesterinen et al. 2011, 
2012). The main hypotheses were that oral health, periodontitis in particular, is more 
severe among diabetic nephropathy patients than other CKD patients, and worse at the 
predialysis stage than at the post-transplantation stage.  
 
The main objectives of the current study were: 
1. To examine the oral health, with an emphasis on periodontal disease, of CKD 
patients at the predialysis stage, and to compare the periodontal health of diabetic 
nephropathy patients and CKD patients with other etiology (Study I). 
 
2. To investigate the association between periodontal inflammatory burden and 
salivary MMP-8 concentration among CKD patients at the predialysis stage (Study 
II). 
 
3. To determine whether oral inflammatory burden associates with mortality and to 
identify causes of death among CKD patients (Study III).  
 
4. To compare, on the individual level, patients? oral health at the baseline predialysis 
stage with that at the follow-up post-transplantation stage (Study IV). 
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PARTICIPANTS AND METHODS 
 
This study is an ongoing clinical investigation of CKD patients examined in 2000?2005 
(baseline) (Vesterinen et al. 2011) and 2013?2015 (follow-up). Originally, 178 CKD 
patients were referred from the Department of Nephrology to the Department of Oral and 
Maxillofacial Diseases, Helsinki University Hospital, Helsinki, Finland, for examination and 
treatment of oral foci of infection prior to ESRD treatment.   
For inclusion, all patients had to have an estimated glomerular filtration rate of < 
20mL/min/1.73 m2, confirmed by a nephrologist. Thus, the patient had to be at the 
predialysis stage, which corresponds to mid CKD Stage 4 (eGFR < 30 mL/min/1.73 m2) 
and Stage 5 (eGFR < 15mL/min/1.73 m2), in terms of the criteria used in our Department 
of Nephrology. Patients below this eGFR are referred for renal replacement therapy. 
Children (< 18-year-olds), pregnant or breastfeeding women, prisoners, and physically or 
mentally disabled patients were excluded. 
Due to the definition of the predialysis stage, 30 patients were excluded from the original 
studies. Of the remaining 148 patients, two had missing periodontal status records and two 
had missing saliva samples at the time of the first study, leaving 144 CKD patients for 
further investigation.  
The study was approved by the Ethical Committee of the Hospital District of Helsinki and 
Uusimaa (Dnro 305/13/03/02/2012) and registered in the hospital database for clinical 
trials.  Written informed consent was obtained from all the patients, and the ethical 
principles of the Declaration of Helsinki were followed throughout the study.  
 
Participants 
PART 1 (Studies I and II) Baseline studies I and II were cross-sectional studies.  
Study I was a clinical study of oral health, with an emphasis on periodontal disease. 
Clinical oral and x-ray examinations were conducted in 2000?2005. Clinical and medical 
data were obtained from the hospital records of 144 patients (47 women), aged 23?83. Of 
these, 52 had diabetic nephropathy and of this 52, 22 suffered from DM2.  
???
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Study II was an MMP-8 salivary study of 118 predialysis patients and 11 systemically and 
periodontally healthy controls. Twenty-six salivary samples of the 144 patients could not 
be examined at the time of MMP-8 analysis due to missing samples. 
 
PART 2 (Studies III and IV) Studies III and IV were follow-up studies with 157 months of 
observation. 
Study III is a follow-up prospective cohort study of 144 CKD patients. Of these, 65 had 
died and 79 survived during the follow-up period of maximal 157 months. The study 
focused on their risk factors of mortality. The cause of death could be recorded for 62 
participants, of which 32 had had diabetic nephropathy. Three patients had died outside 
our hospital district and their cause of death could not be verified. Only ten patients of the 
65 (15%) who has died had undergone a kidney transplant.  
Study IV. Of the 144 CKD patients, 79 had survived and were invited to re-examination 
between 2013 and 2015. Of these, 26 patients dropped out, leaving 53 participants willing 
to participate in the follow-up examination. The study was a longitudinal clinical study that 
focused on comparing the oral health variables of the predialysis and follow-up stages. Of 
the 53 patients, 51 had undergone a kidney transplant and 46 transplants were functioning 
at the time of the examination. Figure 2 shows a flow diagram of the study.   
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Figure 2. Flow diagram of the study 
N= 144  
(N= 52 diabetic nephropathy) 
Predialysis stage (Study I, II) 
N= 79 
Re-called for follow-up study 
N= 53  
(N= 11 diabetic nephropathy) 
Follow-up stage (Study IV) 
N= 65 
(N= 33 diabetic nephropathy) 
Deceased (Study III) 
N= 26 
Drop outs 
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Methods 
Medical records with blood sample analyses from the hospital records were available for 
the study. Mortality records for Study III were obtained from the Causes of Death National 
Database of Statistics Finland. 
 
Oral and radiological examination  
The clinical oral examinations at baseline in 2000?2005 and at follow-up stage in 2013?
2015 were conducted by the same periodontist (HR). The medical records were carefully 
re-examined for the retrospective and follow-up studies.  
Patients underwent a full clinical oral examination, including a mucosal periodontal and 
cariological examination. The number of teeth and implants were recorded, as were fixed 
or removable prosthesis and their condition. Mucosal lesions such as gingival overgrowth, 
coated tongue, ulcers, lichen planus and leukoplakia were also recorded, as well as 
attrition, erosion, diastemas, and mobility of teeth. 
Periodontal recordings were made of all teeth (max 32) and PPDs were measured at six 
sites per tooth with a WHO probe. PPDs were further categorized as no periodontal 
pocket, one or more sites with probing depths of ??????????????????????? 6mm-deep 
periodontal pockets, and two or more further ????????????????-deep periodontal pockets. 
Furcation lesions were recorded. Recessions and clinical attachment levels, as well as 
bleeding on probing, were recorded at the follow-up stage. 
The CDC/AAP?? definition of periodontitis was used, according to which, severe 
periodontitis is when two or more teeth have a CAL of ?????????interproximal sites, and 
one or more teeth with a PPD of ??????????????????? ????????????????????????????????????
defined by two or more teeth with a CAL of ??????????????????? ???????????????????? ????
teeth with a PPD of ??????????????????? ??????????????? that do not fulfil the criteria 
mentioned above are classified as mild or no periodontitis (Page and Eke 2007).  
The following indices were also calculated from dental records and categorized into two 
groups by medians: 
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The DMFT (decayed, missing, filled teeth) index was calculated from 32 teeth in 
accordance with WHO criteria, except for the ????????????????which also took wisdom teeth 
into account.  
TDI was calculated from 32 teeth, taking into account caries, periodontitis, periapical- and 
pericoronitis lesions. This index ranges from 0 to 10 (Mattila et al. 1989).  
PIBI was calculated from 28 teeth. This index adds moderate periodontal pockets (4?
??????????????????????????????????????????????????????????al pockets (Lindy et al. 
2008). 
Panoramic jaw X-rays were taken of all patients at the predialysis and follow-up stages. 
Periapical and bite-wing x-rays were taken when needed.  A specialist in oral radiology at 
our hospital analyzed the X-rays. Baseline X-ray analyses of 17 of the 144 patients were 
missing, leaving 127 available analyses for Study I and III, and 108 available analyses of 
the 118 patients for Study II. For Study IV, five analyses were missing, leaving a total of 
101 analyses available. The radiologist measured alveolar bone loss in each tooth in the 
cervical, middle, and apical thirds of the root lengths.  X-ray analyses were further divided 
into sextants and finally, maximum alveolar bone loss (either horizontal or vertical) was 
recorded. Signs of periapical or pericoronitis lesions, cysts and tumors in the X-rays were 
also recorded. In some cases, when needed, dental radiographs were taken in addition to 
the panoramic jaw X-rays. 
 
Salivary analyses 
Unstimulated and stimulated saliva samples were collected for five minutes in graded test 
tubes and the results were given in ml/min by recording salivary flow rates. Patients were 
asked not to eat or smoke for at least 60 minutes before the examination. Unstimulated 
saliva was collected first, after which paraffin wax was used to stimulate salivary flow. 
Samples were centrifuged for four minutes at 8000 x g at 4o C, and the supernatants were 
frozen at -75 o C for later analyses.  
From the stimulated saliva, MMP-8 was detected by time-resolved immunofluorometric 
assay (IFMA) (Rathnayake et al. 2013a,b, Mäntylä et al. 2006, Leppilahti et al. 2014a,b, 
Gursoy et al. 2010). Catching and tracing monoclonal antibodies (8708 and 8706, Medix 
Biochemica, Kauniainen, Finland) specific to MMP-8, were used. The tracing antibody was 
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labeled by europium-chelate (Hemmilä et al. 1984). Samples were diluted in an assay 
buffer (20mM Tris-HCL (pH7.5), 0.5M NaCl, 5mM CaCl2, 50mM ZnCl2, 0.5% bovine 
serum albumin, 0.05% sodium azide, and 20 mg/L dietylenetriaminepenta-acetic acid) and 
incubated for one hour, followed by incubation with a tracer antibody for another hour. 
Fluorescence was measured five minutes after enhancement solution was added, using 
IFMA. 
 
Questionnaire study 
Self-reported oral health questionnaires were already collected at predialysis and later at 
follow-up.  The questionnaires elicited education, oral health self-care, smoking habits, oral 
symptoms of xerostomia, consideration of the role of oral health in kidney disease, and last 
dental appointment. 
 
Statistical analyses 
A software program (SPSS statistical version 21 and 22) was used for statistical analyses.  
Cross-tabulation and the Pearson chi-square test were used to compare the categorical 
variables in Studies I, II, III, IV. Mean HbA1c values were compared between groups by 
independent samples t-test, and multivariable analyses were conducted using binary 
logistic regression with HbA1c values higher or lower than median as the binary outcome 
variable. 
Study I: As in the previous study by Vesterinen et al. (2011) the oral health of diabetic 
nephropathy patients and other CKD patients were compared. Oral health at ????????????? 
%) and lower (< 6.5 %) HbA1c values was also compared.  
Study II: The concentration of MMP-8 as a continuous variable was compared according 
to the CKD diagnosis and HbA1c values, as well as according to sex-, age-, smoking 
status, number of teeth, TDI and PIBI scores, alveolar bone loss, and PPD categories by 
independent two- samples t-test and Mann-Whitney U test.  
Study III: The Kaplan-Meier survival curve was calculated and the survival distributions of 
the patient groups were compared with the log-rank test. Cox proportional hazards 
regression models were used to analyze the association of clinical oral parameters and 
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other explanatory variables with patient survival. In survival analysis, death was the event 
and all surviving patients were right-censored at the end of follow-up on August 31st 2015. 
Study IV: The oral health data regarding the within-subject changes in the baseline 
(predialysis) and follow-up (post-transplantation) recordings were compared. P-values 
were calculated using the McNemar test for categorical variables, and the Wilcoxon 
signed-rank test for continuous variables. In the comparison between diabetic nephropathy 
and other CKD groups, continuous variables were compared using the Mann-Whitney U 
test and categorical variables using the Pearson chi-square or Fisher test. 
 
Ethical aspect 
This study was approved by the ethical committee of the Helsinki and Uusimaa Hospital 
District. It was conducted in accordance with the principles of the Declaration of Helsinki 
(Dnro 305/13/02/2012).  Written informed consent was obtained from all patients.  
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RESULTS 
 
Baseline results at the predialysis stage are presented in Studies I and II. Basic 
demographic and clinical characteristics are given in Tables 6 and 7.   
 
Oral health with an emphasis on periodontal disease (Study I) 
Diabetic nephropathy patients (N= 52) were compared with other CKD patients (N= 92). 
Other CKD diagnoses included polycystic kidney disease (N= 31), nephrosclerosis (N= 1 
6), immunoglobulin A (IgA)-nephropathy (N= 13), focal segmental glomerulosclerosis (N= 
9), and membranous glomerulonephritis (N= 4). 
Mean HbA1c was 5.7% (±0.8) in the other CKD group, and 8.2% (± 1.6) in the diabetic 
nephropathy group (p<0.001).  
The prevalence of periodontal pockets was high (88%) among CKD patients in general. 
One or more periodontal pockets were observed in 90% of the diabetic nephropathy 
patients and in 87% of those with other CKD diagnoses. 
Patients with diabetic nephropathy diagnosis had worse periodontal health than those with 
other CKD diagnoses. Diabetic nephropathy patients more often had two or more sites 
with a PPD of ?????, and their TDI was higher than that of the other CKD patients (p< 
0.05). Moderate periodontitis diagnosis, assessed by two or more interproximal sites ?????? 
5mm-deep periodontal pockets (not on the same tooth) was more common among diabetic 
nephropathy patients (61.5%) than among those with other CKD diagnoses (47.8%), and 
higher PIBI scores were more common among diabetic nephropathy patients (55.8%) than 
other CKD patients (45.7%), although these results were not statistically significant. 
Diabetes was diagnosed in six patients of the other CKD group, although this was not the 
reason for kidney disease. Thus we also compared patients with different HbA1c values.  
Higher HbA1c ??????%??????????? ??????????????????????????with deep periodontal 
pockets (? ?????????????? ??????????????????? ????????????????????????????????????
interproximal sites ?????? 5mm deep pockets ? not on same tooth), and higher PIBI (p< 
0.05). Patients with a higher HbA1c had a higher TDI score (51.1%) than patients with 
lower HbA1c (40.7%), but this result was not statistically significant. In the multivariable 
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analysis, no oral health parameters, PIBI, TDI, deep periodontal pockets, or background 
variables of sex, age or smoking habits significantly associated with the HbA1c levels. 
There were no statistically significant differences in the number of teeth, alveolar bone loss 
or background variables of age, sex or smoking when diabetic nephropathy patients were 
compared with other CKD patients. However, current smokers had a statistically 
significantly higher TDI score than non-smokers.  
 
Association of salivary MMP-8 with oral inflammatory burden, with an emphasis on 
periodontal disease (Study II) 
Salivary MMP-8 could be analyzed in 118 of the 144 patients. Twenty-six salivary samples 
were missing and could not be analyzed at the time of detection. Salivary samples from 11 
systemically and periodontally healthy individuals were used as controls. 
Higher salivary MMP-8 concentration was associated with poorer oral health. Patients with 
deep periodontal pockets (two or more sites with a PPD of ? 6mm), higher median PIBI 
and TDI associated statistically significantly with higher MMP-8 concentrations (p< 0.05).  
Diabetic nephropathy patients had higher concentrations of salivary MMP-8 (148.66 ± 
????????? ???than the other CKD patients (116.47 ± ????????? ??????????????????????± 93 
?g/ml). The results were not statistically significant, however. Smoking, sex, age, number 
of or different group of medication (antimicrobial or anti-inflammatory drugs, ACE blockers, 
vitamin D or statins) had no statistically significant effect on salivary MMP-8 concentration. 
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The follow-up results are presented in Studies III and IV. Basic demographic and clinical 
characteristics are given in Tables 6 and 7.   
 
Association between oral inflammatory burden and different CKD diagnosis with 
mortality (Study III) 
Maximal follow-up time was 157 months. All 144 patients examined in 2000?2005 were 
called for re-examination in 2013?2015. Of these, 65 had died and 79 survived, of whom 
53 attended the re-examination. The cause of death of 62 patients was verified.  
The most frequent cause of death among the CKD patients was a major cardiovascular 
event (MACE) (N = 31), followed by infection (N = 13) and malignant disease (N = 10). 
Eight patients died for other reasons: one due to a pulmonary embolism, one due to 
calciphylaxia, three due to complications from diabetes, and three due to other chronic 
long-term illnesses. MACE included myocardial infarction, endocarditis, atherosclerotic 
heart disease, valvular heart disease, cardiomyopathy, cardiac arrest, pulmonary edema, 
congestive cardiac failure, and cerebrovascular stroke. Infections included pneumonia, 
sepsis, peritonitis, and herpes encephalitis. Malignant diseases comprised pancreatic 
carcinoma, lymphoma, melanoma, prostate-, urethral-, ovarian-, and colon cancer, and 
one primary cancer of unknown etiology. 
When comparing oral health at baseline (predialysis stage), the deceased had less teeth 
than the patients who survived. They also had higher TDI scores, diabetes more often and 
were older. However, these observations were crude unadjusted results. 
In univariate analysis, moderate periodontitis (HR 1.70, 95% CI 1.019-2.834), number of 
teeth (HR 0.94, 95% CI 0.913-0.965), older age (HR 1.05, 95% CI 1.024-1.071 per one-
year increment), number of medications (HR 1.13, 95% CI 1.042-1.227), and diabetic 
nephropathy diagnosis (HR 2.8, 95% CI 1.684-4.953) were associated with mortality. 
However, in the multivariable Cox regression model, older age (HR 1.03, 95% CI 1.007-
1.058), number of teeth (HR 0.95, 95% CI 0.916-0.981) and diabetic nephropathy 
diagnosis (HR 2.9, 95% CI 1.711-4.837) were significant independent risk factors for death 
(p< 0.05). Therefore, having more teeth seemed to lower the risk of death (HR< 1) (Figure 
3). The 10-year survival rate of diabetic nephropathy patients was 28%, and of the other 
CKD patients 62% (p< 0.001). The overall 10-year survival rate was 50%. 
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Longitudinal study from predialysis (baseline) to post-transplantation (follow-up) 
(Study IV) 
Tables 6 and 7 show the basic demographic and clinical characteristics at follow-up. 
Comparison of within-subject changes at the predialysis and post-transplantation stages 
shows that oral health was better overall at follow-up, when most patients (51 of 53, 
96.2%) had undergone a kidney transplant. Of these transplants, 46 (90.2%) were 
Figure 3.  
Survival analysis calculated using Kaplan-Meier survival curve for patients with 28–32 teeth (0–4 
missing), 23–27 teeth (5–9 missing), and 0–22 teeth (10–32 missing). The log-rank test found a 
statistically significant difference between the 10-year survival rates of patients with 0–22 teeth 
(27.9%), 23–27 teeth (52.2%), and 28–32 teeth (77.3%) (p<0.001). 
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functioning, whereas five patients had returned to dialysis. At baseline, patients more often 
had calculus, deep periodontal pockets, higher TDI and PIBI scores, more teeth, and 
higher salivary flow rates than they did at follow-up. Overall, oral health was poorer at the 
predialysis stage than at follow-up. 
The oral health of the CKD diagnoses groups was also compared at follow-up, as it was in 
the predialysis stage analyses. At follow-up, diabetic nephropathy patients more often had 
plaque, more frequent Candida infections, used more drugs daily, and had lower 
stimulated salivary flow rates than the patients with other CKD diagnose. 
 
 
 
Table 6. Demographic characteristics of CKD patients at baseline (predialysis) and follow-up 
(post-transplantation), in Study I and IV. 
 
 
 
 Predialysis stage (N= 144)  Post-transplantation stage (N= 53) 
 
 Diabetic nephropathy Other CKD    p* Diabetic nephropathy Other CKD    p* 
 (N= 52, 36.1%) (N= 92, 63.9%) (N= 11, 20.8%) (N= 42, 79.2%) 
Sex 
Men 38 (73.1%)  59 (64.1%)   0.271 8 (72.7%)  26 (61.9%)   0.505 
Women 14 (26.9%)  33 (35.9%)  3 (27.3%)  16 (38.1%) 
 
Age (median) 
? 54 yrs 30 (57.7%)  43 (46.7%)   0.207    
> 54 yrs 22 (42.3%)  49 (53.3%)  
 
? 61                  6 (54.5%)  21 (50%)   0.788 
> 61                  5 (45.5%)  21 (50%) 
 
 
Diabetes 
No 0 (0%)  86 (93.5%)  0.000 0 (0%)  39 (92.7%)   0.000 
Yes 52 (100%)  6 (6.5%)  11 (100%)  3 (7.3%) 
 
Smoking** 
No 23 (67.6%)  48 (68.6%)  0.924 5 (83.3%)  26 (83.9%)   0.974 
Yes 11 (32.4%)  22 (31.4%)  1 (16.7%)  5 (16.1%) 
 
Number of 
daily drugs*** 
2?8 14 (26.9%)  66 (71.7%)  0.000    
9?22 38 (73.1%)  26 (28.3%)  
 
3?9     1 (1.9%)  27 (64.3%)   0.001 
10?19       10 (90.9%)  15 (35.9%) 
 
* p-values obtained from Pearson chi-square test. Bold values represent significant (p< 0.05) values. 
**Smoking refers to current smokers, former smokers were excluded 
*** Number of daily drugs categorized by median values 
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DISCUSSION 
 
Rationale for the study 
CKDs are an increasing public health concern globally, along with diabetes, hypertension, 
and obesity, which are their main risk factors.  According to the literature, CVD is the most 
common cause of death among kidney disease patients, followed by infection and cancer 
(Stenvinkel 2002, Kato et al. 2008). Since oral infections such as periodontitis are 
associated with systemic diseases such as diabetes and cardiovascular diseases, oral 
??????????????????????????????????????????????source??of these chronic systemic 
inflammatory diseases. Only a few studies have examined and followed up periodontal 
health among CKD patients both at predialysis and further at post-transplantation stage, 
therefore this study is unique. According to our knowledge, it is also the first study to 
investigate the association between oral health, with an emphasis on missing teeth, and 
mortality among CKD patients. 
Inflammation is indeed a key factor in many chronic diseases, diabetes and periodontitis 
included. There is a well-known two-way relationship between diabetes and periodontitis, 
both of which may stay asymptomatic for years (Taylor et al. 1998, Chapple et al. 2013).  
Periodontitis is also believed to be a non-traditional risk factor for CKD (Fisher et al. 2008). 
In their cross-sectional study, Kshirsagar and co-workers found an association between 
reduced GFR and periodontal disease (Kshirsagar et al 2005). This association could be 
explained by direct damage by periodotopathogens to nephron units, its vasculature or by 
a chronic host inflammatory response to periodontopathogens, leading kidney damage 
(Kshirsagar et al. 2005).  
 
Methodological considerations 
As in the original study by Vesterinen and co-workers (2011) we decided to compare two 
groups of CKD patients: diabetic nephropathy and other CKD, when exploring differences 
in oral health with an emphasis on periodontitis at both the predialysis and follow-up 
stages. Unfortunately, age- and sex-matched controls were lacking.  
???
?
Since diabetes was also diagnosed in 6 out of 92 other CKD patients, we decided to 
compare patients with different HbA1c values in Studies I and II.  As , the two-way 
relationship between diabetes and periodontitis is well known and generally accepted, we 
assumed that diabetic nephropathy patients would also have worse periodontal health 
than the other CKD patients. According to our knowledge, no other clinical longitudinal 
study has investigated the differences between these two subgroups of CKD from 
predialysis to post-transplantation, with an emphasis on periodontitis.  
We have previously studied oral health among CKD patients in general, and the 
periodontal data in the research were reported by the fairy crude World Health 
Organization (WHO) CPITN index (Vesterinen et al. 2011). This index is a practical tool for 
population studies and was developed for the purpose of assessing periodontal treatment 
needs (Ainamo et al. 1982). Since it provides the highest score per mouth sextant, it takes 
into account only a few teeth. In the present study, the periodontal status was thus 
analyzed in more detail at six sites in 32 teeth.  
The clinical and radiographic oral and periodontal examination combined with salivary 
analyses were conducted very precisely, as explained earlier. Data were then collected 
from the patients´ files. Periodontal pocket depths were calculated from periodontal status 
sheets not only from sextants but at six sites per tooth in 32 teeth. Periodontal pockets 
were further ??????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????? ??????????????????????????????????????
pockets. We thought that since we included wisdom teeth, two or more sites with deep 
pockets were more accurate than only one deep pocket due to the possibilities of 
???????????????? Further, we decided to use PIBI to describe the inflammatory burden of 
periodontitis. This index emphasizes deep pockets and is calculated from six sites in 28 
teeth. We were willing to use a well-accepted case definition for periodontitis: The 
CDC/AAP definition. However, since CAL was not reported at baseline, only periodontal 
pockets could be utilized for the classification. Thus, we included the definition of moderate 
periodontitis when two or more teeth had a PPD of ? 5mm at interproximal sites (not on 
the same tooth) excluding the severe and mild forms. In addition, holistic oral inflammatory 
burden was assessed by using TDI, since it takes into account not only periodontitis but 
also the caries, periapical-, and pericoronitis lesions from 32 teeth.  
 
???
?
Ethical aspects 
The study was approved by the Ethical Committee of the Hospital District of Helsinki and 
Uusimaa and written informed consent was obtained from all the patients. Finland is a 
welfare state in which social welfare and health care are guided by the Ministry of Social 
Affairs and Health. According to the Constitution of Finland, public authorities must 
guarantee equal health care services in both preventive primary health care and in highly 
specialized medical care to everyone. Patients with CKD are later possible kidney 
transplant candidates and are therefore screened and treated for oral inflammatory foci.  
Patients who were willing to participate in our studies were examined and treated at both 
the Department of Nephrology and the Departments of Oral and Maxillofacial Diseases at 
the University Hospital, Helsinki, Finland. The hospital environment is ideal for these 
patients as it offers a variety of specialized consultation, the possibility to monitor the 
medically compromised patient and the necessary laboratory tests. Unfortunately, 
worldwide, there is inequity in access to RRT, as it is estimated that over 6 million patients 
cannot access the affordable treatment of RRT (Robinson et al. 2016).  
 
General discussion of results 
Our observation in the cross-sectional baseline study at predialysis stage (Study I) was 
that CKD patients with diabetic nephropathy and with high HbA1c values ??????%????
48mmol/mol) indeed had poorer oral health with emphasis on periodontitis, determined by 
deep periodontal pockets and PIBI scores in addition with higher TDI compared with the 
other CKD patients and with those who had low HbA1c values (< 6.5%, < 48mmol/mol). 
This finding supplements our earlier study which found no differences when using a fairly 
crude CPI to describe the periodontal health of this same patient material (Vesterinen et al. 
2011).  After multivariable analyses, no oral health parameters, PIBI, TDI, deep 
periodontal pockets, or background variables of sex, age or smoking habits significantly 
associated with the HbA1c levels. Although we lacked a control group, our finding is in line 
with a study by Thorman and co-workers in which uremic patients showed a worse DMFT 
index, more periodontal loss of attachment and periapical lesions than age- and sex-
matched controls (Thorman et al. 2009).  Since oral diseases such as periodontitis cause 
low grade systemic inflammation, potential sources of inflammation should be diagnosed 
???
?
and treated early, at the latest at the predialysis stage, prior to entering kidney 
replacement therapy ? dialysis or kidney transplantation.  
The diagnosis of periodontitis has conventionally been based on clinical and radiological 
examination. Since there is variation in the definition of periodontitis, biomarkers or their 
combinations reflecting oral inflammation could supplement clinical oral examination or 
even serve as a screening tool. Oral fluids contain many potential biomarkers associated 
with local or systemic diseases such as IL-????-6 and -8, TNF-??????-8,-9, TIMP-1, and 
sTREM-1 (Rathnayake et al. 2017, Bostanci et al. 2013). A specific biomarker test that 
could provide additional information of oral inflammatory burden could be helpful, 
especially for hospitalized patients or when screening risk groups such as CKD patients. In 
fact, oral fluid (GCF, PISF, mouth rinse or saliva) chair-side/point-of care diagnostics of 
host-inflammatory biomarker MMP-8 could provide an insight into predicting, diagnosing 
and determining the progressive phases of periodontitis, and help in monitoring treatment 
success and medication (Sorsa et al. 2016). In Study II, as hypothesized, salivary MMP-8 
concentration indeed reflected oral inflammatory burden among our CKD patients. 
Elevated salivary MMP-8 associated significantly with poorer oral health assessed by deep 
periodontal pockets and higher PIBI and TDI scores. This finding is in line with other 
clinical oral fluid MMP-8 studies which have shown MMP-8 to associate with severe 
periodontitis (Sorsa et al. 2004, 2006, Leppilahti et al. 2011, Rathnayake et al. 2013a). An 
important finding was that there was no statistically significant association between the 
total number of daily drugs (N =?2?22) or the specific subgroup of medications assessed, 
whether antimicrobial or anti-inflammatory, (N = 19 subgroups according to the Finnish 
catalog of drugs; Pharmaca Fennica Lääketietokanta) and salivary MMP-8 concentrations.  
Smoking seemed to depress MMP-8 concentration, but not statistically significantly when 
compared with non-smokers. Salivary MMP-8 screening could be a beneficial aid for the 
diagnostics of oral foci of infections at the predialysis stage.  
As said earlier, among CKD patients the main cause of death is CVD, followed by 
infections, and this was also the case in our study (Study III). The primary cause of death 
among CKD patients was a MACE (N= 31) followed by infections (N= 13).  In the literature, 
CVDs are mostly explained by dyslipidemia, smoking, hypertension and excess 
phosphate, although low-grade systemic inflammation such as chronic oral infections have 
been proposed to explain part of the disease. The main finding in our third study (Study 
III)  was a statistically significant difference between the 10-year survival rates of patients 
???
?
with 0?22 teeth (27.9%), 23?27 teeth (52.2%), and 28?32 teeth (77.3%) according to the 
log-rank test (p < 0.001). This finding could indeed reflect long-lasting low-level oral 
inflammation among the patients. This finding is new among CKD patients and is in line 
with studies on missing teeth and mortality. A prospective cohort study of 7674 patients 
with 12 years follow-up showed that the number of teeth was highly predictive for all-cause 
mortality of CVD and CHD, and revealed a seven-fold risk of mortality due to CHD in 
subjects with < 10 teeth compared to those with > 25 teeth (Holmlund et al. 2010). 
According to a Finnish population-based survey, even a few missing teeth may predict 
cardiovascular events, diabetes and death (Liljestrand et al. 2015). In the present study, 
10-year survival rate was 28% among diabetic nephropathy patients and 62% among 
those with other CKD diagnoses, indicating a higher risk of mortality among diabetic 
nephropathy patients.  
Since poor oral health is associated with systemic diseases in general, and missing teeth 
with cardiovascular disease mortality, CKD patients and clinicians should be informed and 
motivated regarding the importance of regular oral examination, accurate diagnosis and 
proper treatment in order to reduce the systemic inflammation at every stage of the CKD 
(Meurman et al. 2004, Holmlund et al. 2010).  
The second part of the present follow-up study (Study IV) focused on comparing the oral 
health variables of the 53 CKD patients at predialysis and follow-up. To the best of our 
knowledge, our earlier study is the only longitudinal study to follow up CKD patients (N = 
9) from predialysis to the post-transplantation stage (Vesterinen et al. 2007).  The patients 
were now followed up for 157 months, at which point most patients had already received a 
kidney transplant (51 patients out of 53). Of the transplants, 46/51 were functioning at the 
time of our investigation. Oral health was better overall at the follow-up stage. At 
predialysis, more calculus and deep periodontal pockets were detected, as well as higher 
PIBI and TDI scores. The number of teeth was also higher, and higher salivary flow rates 
were measured than at follow-up, at which time oral health was better overall. This finding 
is promising as regards the efficacy of the focus eradication protocol followed in our 
hospital, where all patients are examined and treated by a dentist at the predialysis stage, 
prior to entering dialysis or being put on the renal transplantation list. We might speculate 
that treating the foci of oral infections at predialysis stage has indeed long-lasting effects, 
although patients are enrolled for supportive therapy after predialysis stage and this might 
also have an impact. 
???
?
At follow-up, diabetic nephropathy patients were compared with the other CKD patients, as 
at the predialysis stage. Our observation was that diabetic nephropathy patients had lower 
stimulated salivary flow rates, showed more dental plaque and candidiasis, and used more 
drugs daily (for example calcium channel blockers) than the other CKD patients. It was 
surprising, however, that the diabetic nephropathy patients did not consider oral health 
care as important for their kidney disease, as did the other CKD patients. However, 
analysis of the questionnaire results revealed no difference between the oral self-care of 
the groups.  
Previously, kidney diseases and oral health have mostly been investigated during dialysis 
and at the post-transplant stage. Bots and co-workers observed that salivary flow rate 
increased after transplantation, and bleeding on probing decreased (Bots et al. 2007). 
They discussed that the salivary flow rate is reversible and is restored after transplantation 
(Bots et al. 2007). Thorman and co-workers, on the other hand, found in their cross-
sectional study, that uremic patients in predialysis or dialysis had higher DMFT index 
scores, more periodontal loss of attachments and more periapical lesions compared with 
the healthy sex- and age-matched controls (Thorman et al. 2009). A recent multinational 
study on over 4000 dialysis patients showed that oral diseases such as dental erosion 
?47%, (95% CI 45.3 ? 48.8)??and moderate or severe periodontitis ?20.6%, (95% CI 19.4 ? 
21.9)? were very common among hemodialysis patients (Palmer et al. 2016).  
Our longitudinal study (over 13 years) is important, as it is the first to provide follow-up 
information of 144 CKD patients? oral health from predialysis to post-transplantation stage.  
 
Limitations of the study 
Limitations of the present series of studies were the lack of control group, and that the 
number of participants was quite low. Age- and sex-matched healthy controls would have 
yielded valuable information. Another limitation is that we could not relate oral health and 
progression of CKD, as we did not examine the patients at dialysis stage but  examined 
this small number of patients (N = 53) in two stages, first at the predialysis stage (mid-CKD 
stages 4 and 5) and secondly at follow-up (after transplantation). Moreover, CKD patients 
at Stages 1 to 3 would have provided more valuable information for attempting to relate 
oral health to CKD progression. However, we found that the survival rate was lower for 
those who had less teeth at predialysis stage, which we might speculate reflects the 
???
?
accumulation of oral inflammation throughout the patient?s life. As this was a continuing 
investigation of the original study conducted in 2000?2005, these weaknesses could not 
be avoided due to the nature of the original study protocol. However, our original aim was 
to study the eventual differences in oral health parameters between diabetic and non-
diabetic CKD patients. Our hypothesis was that diabetic patients would show more 
problems in this regard, and this hypothesis was indeed confirmed by our results. The 
drawbacks of Studies I and II were that we could not take into account bleeding on 
probing, Plaque Index or CAL, as the parameters had not been reported systemically at 
baseline.  
 
Strengths of the study 
The strength of our study was the longitudinal design in which patients were followed from 
the predialysis to the post-transplantation stage (total follow up time over 13 years) in our 
university hospital which is the only national center for organ transplant operations. This is 
a unique study not only because of its longitudinal design but also since the same 
experienced periodontist performed the oral health examinations on all the patients, at 
both the predialysis and post-transplantation stages. In this way, we avoided inter-
examiner variation.   
 
Practical relevance 
Since predialysis patients are potential dialysis patients and later potential transplantation 
recipients, oral infectious foci should be diagnosed and treated at the early predialysis 
stage to avoid serious consequences such as later graft infection. Helenius-Hietala and 
co-workers observed that poor oral health in liver transplant patients indeed affects 
prognosis (Helenius-Hietala et al. 2013). Accordingly, poor oral health has shown to 
associate with an increased risk of acute one-year rejection one year after renal 
transplantation (Zwiech et al. 2013). 
The number of patients with ESRD is increasing, and patients seek dental care at different 
stages of renal disease. The present series of studies presented observations of oral 
health, comparing diabetic nephropathy patients with patients with other CKD diagnoses. 
Since oral inflammatory diseases are mostly treatable risk factors for many systemic 
???
?
complications, the importance of cooperation between physicians and dentists cannot be 
overemphasized. 
 
Further research 
Since CKDs together with their main risk factor of diabetes are increasing, more long-term 
follow up studies with a larger number of CKD patients and a control group are needed to 
evaluate the effect of oral infection burden on the progression of CKD and quality of life of 
these patients. Saliva as a diagnostic fluid of oral and systemic inflammation is an 
interesting topic and could be explored further to analyze different molecular biomarkers 
and their combinations in screening, predicting, diagnosing and determining the 
progressive phases of oral and systemic diseases. CKD patients in the dialysis phase 
need special attention. For example the infection sources of peritonitis or sepsis are not 
currently fully understood and the mouth may be one infection source that should be 
studied in more detail within these patients. Further studies on these issues are ongoing.  
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CONCLUSIONS 
 
This thesis consists of four further clinical oral studies of CKD patients originally examined 
in 2000?2005 at the predialysis stage in the Department of Oral and Maxillofacial Diseases 
of Helsinki University Hospital (Vesterinen et al. 2011).  
The main objectives were: to study oral health, with an emphasis on periodontitis, among 
CKD patients in more detail than in the previous study (Vesterinen et al. 2011) (Study I); to 
investigate whether salivary MMP-8 concentration can reflect oral inflammatory burden at 
the predialysis stage (Study II); to clarify the association between oral inflammatory burden 
and mortality (Study III); and to compare oral health at predialysis and follow-up (Study IV). 
The following conclusions can be drawn from these studies:  
In general, the p?????????????????????????????????????????????????????????? was high (88 
%) among CKD patients at the predialysis stage and patients with diabetic nephropathy 
had poorer periodontal health. As patients at the predialysis stage are prospective dialysis 
patients and kidney transplant recipients, potential sources of systemic inflammation, such 
as periodontitis, should be diagnosed and treated on time. Patients with diabetic 
nephropathy should receive special attention. 
Higher salivary MMP-8 concentration was associated with poorer oral health (Study II). 
Salivary MMP-8 screening could thus be a beneficial aid for infection foci diagnostics 
among CKD patients.  
According to the follow-up study, fewer teeth significantly associated with risk of death 
even after adjustment for the known risk factors age and diabetes (Study III).  Most 
frequent cause of death among CKD patients was a major adverse cardiovascular event, 
followed by infection and then malignant disease. Risk of death was higher among patients 
with diabetes nephropathy (Study III).  
As was shown in Study IV, oral health was better at follow-up than in the predialysis stage 
during which oral infection treatment was performed. However, diabetic nephropathy 
patients should be paid special attention, as oral health with an emphasis on periodontitis 
seems to be poorer among this special group of patients.  
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